BioMarin Pharmaceutical
(NASDAQ) BMRN
BioMarin Pharmaceutical Financials at a Glance
Market Cap
$11.08B
Revenue (TTM)
$3.24B
Net Income (TTM)
$268.74M
EPS (TTM)
$1.37
P/E Ratio
41.85
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Price
$59.00
Volume
3,709,815.533
Open
$57.35
Price
$59.00
Volume
3,709,815.533
Open
$57.35
Previous Close
$59.00
Daily Range
$57.35 - $59.77
52-Week Range
$49.26 - $66.28
Estimated Earnings Date
Aug 3, 2026
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Price
$59.00
Volume
3,709,815.533
Open
$57.35
Previous Close
$59.00
Daily Range
$57.35 - $59.77
52-Week Range
$49.26 - $66.28
Estimated Earnings Date
Aug 3, 2026
BMRN News
BMRN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioMarin Pharmaceutical
Industry
Biotechnology
Sector
Health CareEmployees
3,221
CEO
Alexander Hardy
Website
www.biomarin.comHeadquarters
San Rafael, CA 94901, US
BMRN Financials
Key Financial Metrics (TTM)
Gross Margin
75.93%
Operating Margin
13.55%
Net Income Margin
8.29%
Return on Equity
4.41%
Return on Capital
7.93%
Return on Assets
3.13%
Earnings Yield
2.39%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$11.08B
Shares Outstanding
193.28M
Volume
3.71M
Avg. Volume
2.03M
Financials (TTM)
Gross Profit
$2.46B
Operating Income
$439.21M
EBITDA
$482.49M
Operating Cash Flow
$874.25M
Capital Expenditure
-$107.19M
Free Cash Flow
$767.06M
Cash & ST Invst.
$2.22B
Total Debt
$1.44B
BioMarin Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$766.21M
+2.8%
Gross Profit
$571.21M
-3.8%
Gross Margin
74.55%
N/A
Market Cap
$11.08B
N/A
Market Cap/Employee
$3.65M
N/A
Employees
3,040
N/A
Net Income
$105.53M
-43.2%
EBITDA
$172.57M
-34.4%
Quarterly Fundamentals
Total Cash
$2.22B
+74.7%
Total Debt
$1.44B
+139.2%
Accounts Receivable
$903.91M
+22.3%
Inventory
$1.27B
-0.1%
Long Term Debt
$1.43B
+140.1%
Short Term Debt
$9.32M
+47.7%
Return on Assets
3.13%
N/A
Return on Invested Capital
5.63%
N/A
Free Cash Flow
$199.73M
+26.7%
Operating Cash Flow
$220.65M
+26.5%